Last updated: 2026-09-12 00:06:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Axsome Therapeutics, Inc. (AXSM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $220.68, with a market capitalization of $11.03B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $112.90 to $260.19. This page covers its latest market performance, valuation, price trends and company information.
$11.03B | |
$212.71 | |
$260.19 | |
$1.94 | |
$211.12 | |
979.82K | |
828.92K | |
-- | |
$260.19 | |
$112.90 | |
-- | |
-- |
Axsome Therapeutics, Inc. (AXSM) last closed at $211.12 as of 2026-09-11 23:53:00, unchanged from the previous close of $211.12.
During the latest regular trading session, AXSM traded between $1.94 and $260.19, with a volume of 979.82K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Axsome Therapeutics, Inc. (AXSM) moved from $202.83 to $220.68, representing a gain of 8.80% ($17.85).
The stock traded between $199.71 and $229.01 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 514.59 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 73.2%
AXSM is currently trading at $220.68, placing it 73.2% of the way from its 52-week low of $112.90 to its 52-week high of $260.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 925 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Axsome Therapeutics, Inc. (AXSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.